Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab Only

Clinical trial NCT01434303 · COMPLETED

Trial details

NCT number

NCT01434303

Sponsor

National Cancer Institute (NCI)

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2012-01-10

Primary completion

2016-02-16

Enrollment

37

View on ClinicalTrials.gov